🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is an efficacy and safety study of ertugliflozin in participants with ...
Status
Completed
Location
Multiple Locations
Start Date
2013-12-13
Trial ID
NCT02033889
This is a study to evaluate the efficacy and safety of ertugliflozin (MK-88...
Status
Completed
Location
Multiple Locations
Start Date
2014-09-23
Trial ID
NCT02226003
Treatments Being Tested
This prospective, randomized, open-label, blinded endpoint (PROBE) trial ev...
Status
Not Yet Recruiting
Location
Zhongshan Hospital, Fudan University
Start Date
2026-07-01
Trial ID
NCT07621380
Treatments Being Tested
This study will evaluate the efficacy and safety of ertugliflozin (MK-8835/...
Status
Completed
Location
Multiple Locations
Start Date
2013-12-02
Trial ID
NCT01986855
Treatments Being Tested
MK-8835-016 (B1521006) is designed to evaluate the safety and efficacy of a...
Status
Completed
Location
Multiple Locations
Start Date
2010-02-24
Trial ID
NCT01059825
This is a safety and efficacy study of ertugliflozin (MK-8835/PF-04971729) ...
Status
Completed
Location
Multiple Locations
Start Date
2014-03-12
Trial ID
NCT02036515
The purpose of this study is to examine the rate and extent of absorption o...
Status
Completed
Location
Multiple Locations
Start Date
2010-05
Trial ID
NCT01114568
Treatments Being Tested
Ertugliflozin (PF-04971729, MK-8835) is a new compound proposed for the tre...
Status
Completed
Location
Multiple Locations
Start Date
2009-10-16
Trial ID
NCT00989079
Treatments Being Tested
This is a study of co-administration of ertugliflozin (MK-8835/PF-04971729)...
Status
Completed
Location
Multiple Locations
Start Date
2014-04-22
Trial ID
NCT02099110
This is a study to evaluate the efficacy and safety of the addition of ertu...
Status
Completed
Location
Multiple Locations
Start Date
2015-12-16
Trial ID
NCT02630706
Treatments Being Tested